This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Nektar Therapeutics Inc (NKTR)

NASDAQ: Health Care

Company Balance Sheet
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Assets
Cash and Equivalents 55.57M 12.37M 39.07M 25.44M
Receivables 19.95M 3.61M 2.23M 5.80M
Inventories 11.35M 12.95M 13.45M 18.27M
Other Current Assets 9.81M 8.82M 5.17M 13.36M
Total Current Assets 350.05M 288.20M 257.88M 314.63M
Property, Plant & Equipment, Gross 174.05M 164.18M 151.12M 144.88M
Accumulated Depreciation & Depletion 102.71M 93.81M 84.15M 72.67M
Property, Plant & Equipment, Net 71.34M 70.37M 66.97M 72.22M
Intangibles 0.00 0.00 0.00 0.00
Other Non-Current Assets 4.17M 6.55M 33.17M 34.44M
Total Non-Current Assets 152.01M 153.42M 176.65M 183.16M
Liabilities & Shareholder Equity
Total Assets 502.06M 441.62M 434.53M 497.79M
Accounts Payable 2.36M 2.70M 9.12M 2.86M
Short Term Debt 4.76M 4.51M 0.00 0.00
Other Current Liabilities 10.13M 5.57M 21.12M 12.41M
Total Current Liabilities 61.25M 64.05M 98.22M 78.54M
Long Term Debt 242.12M 125.00M 125.00M 125.00M
Deferred Income Taxes 0.00 0.00 0.00 0.00
Other Non-Current Liabilities 191.20M 212.10M 293.16M 235.63M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 434.39M 341.24M 426.21M 372.24M
Total Liabilities 495.63M 405.29M 524.43M 450.77M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 6.43M 36.33M -89.90M 47.02M
Common Par 13.00K 13.00K 11.00K 11.00K
Additional Paid In Capital 1.88B 1.82B 1.64B 1.62B
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -1.87B -1.79B -1.73B -1.57B
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments -2.17M -1.57M -1.18M -357.00K
Total Capitalization 248.54M 161.33M 35.10M 172.02M
Total Equity 6.43M 36.33M -89.90M 47.02M
Total Liabilities & Stock Equity 502.06M 441.62M 434.53M 497.79M
Total Common Shares Outstanding 135.29M 131.22M 116.49M 115.26M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 132.46M 126.87M 115.73M 114.82M
Diluted Weighted Shares Outstanding 132.46M 126.87M 115.73M 114.82M
Number of Employees 425 438 445 433
Number of Part-Time Employees 0 0 0 0
NKTR News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

NKTR Nektar Therapeutics Inc

Chart of NKTR

Analysts Ratings for NKTR

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 7 7 8 7
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 1 1 1 1
Strong Sell 0 0 0 0
GET NKTR ANALYST REPORT

NKTR Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs